Clinical Trials Logo

Discogenic Pain clinical trials

View clinical trials related to Discogenic Pain.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04673461 Active, not recruiting - Discogenic Pain Clinical Trials

Study Investigating STA363 Compared to Placebo in Patients With Chronic Discogenic Low Back Pain

STA-02
Start date: July 31, 2020
Phase: Phase 2
Study type: Interventional

This is a phase IIb, prospective, multi-country, multicenter, randomized, double-blind, placebo-controlled, parallel group study to investigate the efficacy, safety and transformation of NP following single intradiscal injection of STA363 (lactic acid) into one or two IVDs compared to placebo for the treatment of discogenic low back pain. This study will be conducted in Russia, Spain and the Netherlands.

NCT ID: NCT03958604 Active, not recruiting - Low Back Pain Clinical Trials

Burst Neurostimulation for Discogenic Low Back Pain

Start date: May 28, 2019
Phase: N/A
Study type: Interventional

The purpose of this prospective post market pilot study is to evaluate the effect of Burst Spinal Cord Stimulation(B-SCS) in the management of chronic discogenic pain in subjects who are refractory to other available treatments. Selected subjects will not be suitable candidates for lumbar spinal surgery and will meet the standard selection process for SCS as routinely utilized in the study centers. Results from this pilot study will inform current clinical practice and future comparative studies in this specific population. Eligible subjects for B-SCS will be asked to participate in this study. If they decide to participate, they will be treated with the Prodigy TM and Proclaim TM (Abbott Laboratories) SCS system and prospectively followed for 12 months following implantation.